In addition, due to deletion of PTEN that represents one of the most frequent prostate cancer genetic alteration, prostate tumorigenesis is promoted by BMI-1-mediated repression of ER-β that enables the HIF-1α/VEGF signaling altered in PCa cells [62]. The gene discussed is ESR2; the disease is posterior cortical atrophy.